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Nucleoporin Nup62 localizes at the central channel
of the nuclear pore complex and is essential for
nucleocytoplasmic transport. Through its FG-repeat
domain, Nup62 regulates nuclear pore permeability and
binds nuclear transport receptors. Here, we report that
Nup62 interacts directly with Exo70 and colocalizes with
Exo70 at the leading edge of migrating cells. Nup62 binds
the N-terminal domain of Exo70 through its coiled-coil
domain but not through its FG-repeat domain. Selective
inhibition of leading edge Nup62 using RNA interference
significantly reduces cell migration. Furthermore, Exo70
recruits Nup62 at the plasma membrane and at filopodia.
Removal of the Exo70-binding domain of Nup62 prevents
leading edge localization of Nup62. Analogous to Exo70,
Nup62 cycles between the plasma membrane and
the perinuclear recycling compartment. Altogether, we
propose that Nup62 not solely regulates access to the cell
nucleus, but additionally functions in conjunction with
Exo70, a key regulator of exocytosis and actin dynamics,
at the leading edge of migrating cells.
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Nucleoporins are the major components of the nuclear
pore complex (NPC), a large proteinacious structure that
perforates the nuclear envelope and controls nucleocy-
toplasmic transport of macromolecules (reviewed in (1)).
Nucleoporin p62 (Nup62) is present in two NPC mod-
ules, the Nup62-Nup58-Nup45-Nup54 and the Nup214-
Nup88-Nup62 subcomplexes (2). Nup62 is composed
of two dissimilar domains: an intrinsically disordered
FG-repeat containing N-terminal domain (amino acids
1–327) and an α-helical coiled-coil domain (amino acids
328–522). Nup62 is anchored at the NPC mainly via its
coiled-coil domain that provides structure and targeting
information (3–5). The FG-repeat domain on the other
hand contributes directly to nucleocytoplasmic transport
through direct interactions with nuclear transport recep-
tors and – occasionally – with cargo (6,7). Nup62 inter-
acts directly with nuclear transport factor 2 (NTF2) through
its FG-repeat domain (8–10) and this interaction is essen-
tial for the transport activity of NTF2 (7,11). Systematic
analysis of nucleoporin dynamics predicts both transport
and structural roles for Nup62 at the NPC (12,13). Further-
more, intermolecular sliding between components of the
Nup62-Nup58-Nup45-Nup54 complex in the central chan-
nel of the NPC is thought to regulate pore diameter (4).
Surprisingly, an increasing number of studies indicate that
some nucleoporins also localize outside the NPC and are
involved in a wide variety of processes apparently unre-
lated to NPC function, including microtubule regulation
in the cytoplasm (14), mitochondria transport (15), gene
transcription (16,17), DNA repair (18), centromere and
kinetochore function in mitosis (19–21), spindle assem-
bly (22,23) and metaphase to anaphase transition (24,25).
Whereas some nucleoporins such as Nup358, Nup98 and
the Nup84/Nup107 complex have been extensively linked
to unexpected physiological functions, this has not yet
been documented for Nup62.
Interestingly, nucleoporins also tend to perform additional
functions at the NPC that are unrelated to nucleocyto-
plasmic transport. Examples are gene transcription at the
yeast NPC (26), coupled nuclear import and sumoylation
of the histone deacetylase HDAC4 by Nup358 (27) and
targeting and repair of damaged DNA (18,28). Notably,
some of these functions, such as Nup358-mediated
sumoylation, are the same as those found at alternative
subcellular localizations.
Exocyst component of 70kDa (Exo70) is a subunit of the
exocyst complex, which is required for tethering of exocy-
totic vesicles at the plasmamembrane. Delivery, tethering
and fusion of exocytotic vesicles with the plasma mem-
brane are essential for many cellular processes, including
insulin secretion in pancreatic β-cells (29), targeting of
matrix metalloproteinases (MMPs) to invadopodia in
breast carcinoma cells (30), insulin-stimulated exocytosis
of the glucose transporter Glut4 in 3T3L1 adipocytes (31),
transport of low-density lipoprotein (LDL) receptors to
the basolateral membrane of Madin-Darby canine kidney
(MDCK) cells (32), granule secretion in platelets at sites
of vascular injury (33), neurotransmitter release in the
synapses of neurons (34), delivery of secretory vesicles
to sites of dynamic plasma membrane expansion at
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the leading edge of migrating cells (35) and membrane
transport to the midbody ring of dividing HeLa cells to
perform the physical separation of daughter cells (36).
The exocyst complex is evolutionarily conserved and is
composed of eight subunits: Sec3, Sec5, Sec6, Sec8,
Sec10, Sec15, Exo70 and Exo84. Exo70 interacts directly
with phosphatidylinositol 4,5-bisphosphate (PIP2) via its C-
terminus, and together with Sec3 anchors the remaining
exocyst subunits to the plasma membrane (37,38). Exo70
is composed of three domains (39): the N-domain (amino
acids 1–393) that interacts with other exocyst subunits
and with the small RhoGTPase TC10 (reviewed in (40)),
and the C-terminus that interacts with the Arpc1A
component of the Arp2/3 complex (41) and is composed
of the M-domain (amino acids 394–538) and the C-domain
(amino acids 539–653).
In many cell systems, expression of Exo70 induces
multiple filopodia-like membrane protrusions. Exo70 has
been shown to bind directly to the Arp2/3 complex
in an EGF-regulated manner. Furthermore, inhibition
of Exo70 represses Arp2/3 recruitment at the leading
edge and blocks formation of actin-based membrane
protrusions (41). Upon nerve growth factor (NGF)-induced
differentiation of rat pheochromocytoma (PC12) cells,
Exo70 interacts with the activated form of TC10
and targets the Exo70-TC10 complex to sites of
membrane protrusions where it locally prevents Cdc42-
dependent activation of Neural Wiskott-Aldrich syndrome
protein (N-WASP), probably reflecting local morphological
specialization (42).
Migration of eukaryotes requires coordinated adhesion,
actin polymerization and sustained membrane traffic
between the perinuclear recycling compartment and the
leading edge of motile cells. Plasma membrane proteins
such as integrins have been shown to be continuously
internalized and recycled back to the cell front (reviewed
in (43)). Delivery of transport vesicles at the cell surface
involves vesicle tethering by the exocyst complex and
SNARE-mediated fusion with the target membrane.
Inhibition of vesicle delivery at the cell front impairs cell
migration (44).
Generally, nucleoporins tend to display auxiliary functions
in other cellular compartments or specialized structures
such as the nuclear interior or the mitotic apparatus.
It is therefore of interest to screen nucleoporins
for unconventional localization and function. Moreover,
nucleoporins with intrinsically disordered domains such as
Nup62 are of special interest given that such domains have
been found to be characteristic of higher organisms (45).
In the present study, we report that Nup62 is required
for cell migration and is recruited by Exo70 at the leading
edge of migrating cells.
Results
Nup62 localizes at the leading edge of cells
Subcellular localization of Nup62 using immunofluores-
cence microscopy of cultured cells revealed that in
addition to the expected nuclear membrane localization,
Nup62 displays nucleoplasmic, perinuclear, cytoplasmic
and midbody ring staining (Figure 1 and data not shown).
Furthermore, HeLa cells that were stimulated with Epi-
dermal growth factor (EGF) exhibited Nup62 recruitment
at membrane protrusions resembling membrane ruffles
(Figure 1A), and Human Embryonic Kidney 293 (HEK)
cells transfected with the constitutively activated Rac
Q61L mutant displayed Nup62 localization at induced
lamellipodia (Figure 1B). In a sparsely seeded culture
of Human prostate cancer (PC3) cells, Nup62 colocal-
ized with Exo70 at lamellipodia (Figure 1C). To exclude
a possible immunostaining artifact, we also analysed
the subcellular localization of enhanced green fluores-
cent protein (EGFP)-coupled Nup62. Both EGFP-Nup62
and Nup62-EGFP localized at the nuclear membrane and
Figure 1: Nup62 localizes at the leading edge of migrating cells. A) Immunolocalization of endogenous Nup62 and Arp3 in
EGF-stimulated HeLa cells and (B) in Rac Q61L transfected HEK cells. C) Colocalization of endogenous Nup62 and Exo70 at the cell
leading edge in a sparsely seeded culture of PC3 cells. Scale bar, 10 μm.
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at actin-related protein 3 (Arp3)-positive membrane protru-
sions (Figure S1A). Because nuclear pore Nup62 functions
in the Nup62-Nup58-Nup45-Nup54 and Nup214-Nup88-
Nup62 subcomplexes, we also investigated if we could
detect these other nucleoporins atmembrane protrusions.
Nup88, Nup58/45 and Nup54 were found to localize at
actin-based membrane protrusions (Figure S1B).
Colocalization with the midbody ring marker mitotic
kinesin-like protein (MKLP1) in HeLa cells revealed that
Nup62 localizes at the midbody ring just before or after
completion of abscission (data not shown). Although it
is known that the midbody ring persists for some time
after abscission (36), no postmitotic function has yet been
reported for the midbody ring.
Nup62 is involved in cell migration
As our results indicate that Nup62 is present at the leading
edge of migrating cells, we postulated that Nup62 is
involved in cell migration. To test this hypothesis, we
down regulated Nup62 expression by RNA interference
in PC3 cells and performed a standard wound-healing
assay (Figure 2A). Nup62 down regulation was more than
90% (Figure 2B) and both cytoplasmic and leading edge
Nup62 pools almost completely disappeared (Figure 2C).
Mock-transfected cells and cells transfected with control
small interfering RNAs behaved similarly and migrated
about three times as far as cells transfected with Nup62
small interfering RNAs (1097 ± 125 μmand 1147 ± 40 μm
versus 381 ± 194 μm and 386 ± 206 μm after 24 h). Thus,
down regulation of cytoplasmic and leading edge Nup62
dramatically reduces cell migration. Immunofluorescence
staining of cells from the wound-healing experiment
revealed that the formation of membrane protrusions
was not impaired as a consequence of Nup62 knock-
down (Figure 2C). However, time lapse microscopy of
PC3 cells transfected with Alexa 488-labelled siRNAs
revealed that Nup62 knock-down cells developed larger
ruffling lamellipodia and displayed reduced cell motility
whereas cells transfected with control siRNAs migrated
normally (supplementary video S1 and S2, Figure S2). This
is consistent with a role for Nup62 in membrane transport
to lamellipodia.
To exclude a possible effect of Nup62 knock-down on
global nucleocytoplasmic transport events, we performed
fluorescence-activated cell sorter (FACS) analysis on
mock-transfected HeLa cells as well as on cells
Figure 2: Nup62 regulates cell migra-
tion. A) Migrated distance over time of
PC3 cells transfected with Nup62 siRNAs,
control siRNA or without siRNA (mock) in a
wound-healing assay. Nup62 knock-down
reduces cell migration (n = 9). B) Nup62
knock-down was visualized by western
blotting. Actin was added as a loading
control. C) Immunolocalization of Nup62
and Arp3 at the cell leading edge in
a wound-healing assay following Nup62
knock-down. Nup62 knock-down does not
inhibit the formation of membrane protru-
sions. Note that untransfected cells were
included instead of mock-transfected cells
in (A). Arrowheads indicate the position of
the wound. Scale bar, 10 μm.
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transfected with either control siRNAs or Nup62 siRNAs.
We reasoned that if nucleocytoplasmic transport is
perturbed by Nup62 knock-down, this would have a major
impact on cell cycle progression. However, Nup62 knock-
down had no significant impact on cell cycle progression
because the distribution of cells in the various cell cycle
stages remained unaltered (Figure S3, left panels). We
analysed transfection efficiency by immunofluorescence
microscopy and noticed that almost all cells were
transfected with the Nup62 siRNAs because they lacked
cytoplasmic Nup62 staining in contrast to control cells
(data not shown). This was further confirmed by the
use of Alexa 488-labelled siRNAs that labelled virtually
all cells (Figure S2). To attest that all cells enter the cell
cycle normally, we arrested cells in M phase through
nocodazole treatment to depolymerize microtubules. All
cells entered mitosis normally after Nup62 knock-down
because almost all cells have duplicated their DNA after
24 h (Figure S3, right panels).
Nup62 interacts directly with Exo70
To identify Nup62 interacting proteins, we selected five
midbody ring proteins and analysed their interaction with
Nup62 in a pull-down assay. Cep55, Annexin 11, Aurora B,
Rab11 and Exo70 were expressed as streptavidin binding
peptide (SBP)-fusion proteins in HEK cells together with
untagged Nup62 and subsequently purified using strep-
tavidin Sepharose. Of the tested proteins, only Exo70, a
subunit of the exocyst complex, was able to bind to Nup62
(Figure 3A). The interaction between Nup62 and Exo70
was confirmed by co-immunoprecipitation experiments.
NTF2 was used as a positive control for Nup62 binding (8)
and Sec3, another exocyst subunit, was included to test
the specificity of the interaction. EGFP-tagged Exo70,
Sec3 or NTF2 were transfected in HEK cells together with
untagged Nup62 and Nup62 was subsequently immuno-
precipitated using anti-Nup62 antibody. Nup62 coprecipi-
tated EGFP-Exo70, Exo70-EGFP and NTF2-EGFP but not
EGFP-Sec3 and EGFP (Figure 3B, second panel from
top). Reciprocally, using anti-EGFP antibody, EGFP-Exo70
and Exo70-EGFP but not EGFP-Sec3, EGFP and NTF2-
EGFP coprecipitated Nup62 (Figure 3B, bottom panel).
We also explored the in vivo interaction between both
endogenous proteins. Therefore, we performed immuno-
precipitations on PC3 cell extracts (Figure 3C). Anti-Exo70
antibody co-immunoprecipitated Sec8–another exocyst
component – and Nup62 (Figure 3C, left panel). In con-
trast, anti-Sec8 antibody co-immunoprecipitated Exo70
but not Nup62 (Figure 3C, right panel). To determine
if the proteins can also interact directly, we tested
interaction between recombinant Exo70 and Nup62.
Because all recombinant full-length Nup62 precipitates
in inclusion bodies in Escherichia coli (3), we removed
the intrinsically disordered FG-repeat containing domain
and expressed only the coiled-coil domain (amino acids
328–522) fused to small ubiquitin-like modifier (SUMO)
and V5 tags to improve solubility and detectability as
the monoclonal anti-Nup62 antibody that we used only
recognizes the N-terminal FG-repeat containing domain.
After taking care that the tags are compatible and
do not interfere in our experiment, we uncovered a
direct binding between Exo70 and Nup62 (328–522)
(Figure 3D).
Next, we examined the possibility that the direct
interaction between Exo70 and Nup62 could reflect
Nup62-assisted nuclear import of Exo70-EGFP. However,
inhibition of Chromosome region maintenance 1 (CRM1)-
mediated export of nuclear export sequence (NES)-
containing proteins using Leptomycin B revealed no
change in EGFP-Exo70 localization, suggesting that Exo70
is not shuttling between the cytoplasm and the nucleus
(Figure S1C).
Exo70 recruits Nup62 at the plasma membrane
and at filopodia
Exo70 recruits the Arp2/3 and exocyst complexes at
sites of active membrane protrusion (41,46). Therefore,
we wondered if Nup62 is also recruited at the plasma
membrane by Exo70.When expressed in HEK cells, EGFP-
Exo70 accumulated at the plasma membrane and induced
numerous membrane protrusions (Figure 4A, right panel).
Expressed untagged Nup62 on the other hand localized
mainly in the cytoplasm at perinuclear vesicles and at
membrane ruffles (Figure 4A, left panel). However, when
Nup62 and Exo70 were expressed simultaneously, Nup62
relocalized to filopodia (Figure 4B, right panels), and an
intense plasma membrane staining could be observed
(Figure 4B, left panels). These findings indicate that Exo70,
through interaction with Nup62, recruits the latter to
filopodia and the plasma membrane.
Exo70 recruits Nup62 at internalized PIP2-containing
vesicles triggered by Arf6 Q67L or PIP5K
Exo70 and other exocyst subunits are continuously
cycling between the perinuclear recycling compartment
and the plasma membrane (47–49). Therefore, based
on the previously described colocalization at the plasma
membrane, we wondered if Nup62 could be recruited
by Exo70 through the recycling pathway. EGFP-Exo70
normally localizes at the plasma membrane and at
actin-based membrane protrusions ((41); Figure 5A, left
panel). Exo70 associates with the plasma membrane
through direct interaction between its C-terminus and
PIP2 (38,46). Furthermore, ADP-ribosylation factor 6 (Arf6)
Q67L, a GTP hydrolysis-deficient mutant, and the Arf6
GTP downstream effector enzyme phosphatidylinositol-4-
monophosphate 5-kinase (PIP5K) have been described
to induce cytoplasmic accumulation and fusion of
PIP2-containing vesicles (50). These vesicles represent
internalized membranes that are unable to recycle back to
the plasma membrane because of a block in PIP2 turnover
and become trapped in the cytoplasm. When vesicles
were induced in HEK cells by co-expression of Arf6 Q67L
or PIP5K, we observed accumulation of internalized EGFP-
Exo70 at the surface of these vesicles (Figure 5A, middle
panel and 5C, right panel). A fusion protein of EGFP and
the pleckstrin homology domain from PLCδ (EGFP-PH)
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Figure 3: Nup62 interacts with Exo70. A) Pull-down (PD) of streptavidin binding peptide (SBP)-tagged proteins in HEK cell extracts
using streptavidin Sepharose. The two upper panels show SBP-tagged proteins in total extracts (TE) and enriched on streptavidin
Sepharose (PD). The lower panels show Nup62 in TE and pulled down by the SBP-tagged proteins. B) Immunoprecipitation (IP) of
transfected HEK cell extracts using either anti-Nup62 mouse IgG (upper panels) or anti-EGFP rabbit IgG (lower panels). Proteins were
detected by immunoblotting (IB). Open and full arrowheads are antibody light and heavy chains, respectively. C) Immunoprecipitation
(IP) of endogenous proteins in PC3 cell extracts using either anti-Exo70 mouse IgG (left panel) or anti-Sec8 mouse IgG (right panel).
Proteins were detected by IB. D) Recombinant GST and GST-Exo70 were incubated with equal amounts of recombinant SUMO-V5 or
SUMO-Nup62(328–522)-V5 as indicated on top of the upper panel. GST PD was performed to determine if Nup62(328–522) can bind
directly to Exo70. Precipitated GST constructs were identified by IB using anti-GST antibody. Coprecipitated SUMO-V5 constructs were
identified by IB using anti-V5 antibody.
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Figure 4: Exo70 recruits Nup62 at
the plasma membrane and at filopo-
dia. A) Untagged Nup62 and EGFP-Exo70
transfected separately in HEK cells. Note
the localization of Nup62 in membrane
ruffles and the formation of branched
filopodia by Exo70. B) Nup62 and EGFP-
Exo70 transfected simultaneously in HEK
cells. Exo70 localization remains unal-
tered. Nup62, however, relocalizes to
the plasma membrane (left pannels) and
filopodia (right pannels) and colocalizes
with Exo70. Scale bar, 10 μm.
Figure 5: Exo70 recruits Nup62 on
internalized membranes. Internalized
plasma membrane was prohibited from
recycling through expression of the con-
stitutively activated Arf6-Q67L mutant (A,
B) or the Arf6 effector PIP5 kinase (C, D).
The PIP2-enriched vesicles were coated
with the PIP2-binding proteins PH-PLCδ
or with Exo70, as indicated. NTF2 binds
to Nup62 but fails to localize at the vesi-
cles and was included as a control (B). In
the lower panels (B, D), untagged Nup62
was added as a third component. Nup62
is recruited by Exo70-coated vesicles but
not by PH-PLCδ-coated vesicles (B, D).
Scale bar, 10 μm.
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visualizes PIP2 accumulation at these vesicles (Figure 5A,
right panel and 5C, left panel) and was further used as
a negative control. Co-expressed untagged Nup62 was
clearly targeted to the vesicles containing internalized
EGFP-Exo70 (Figure 5B,D, right panels) but not to those
containing internalized PH-EGFP (Figure 5B, middle panel
and 5D, left panel), regardless if the vesicles were induced
with Arf6 Q67L (Figure 5B) or PIP5K (Figure 5D). As
expected, NTF2-EGFP which interacts with Nup62 but
is not localized at the plasma membrane or the vesicles
could not recruit Nup62 at the vesicles (Figure 5B, left
panel).
Nup62 marks out the recycling pathway
in conjunction with Exo70
We observed perinuclear localization of untagged Nup62
that concentrates in different parts around the centrosome
(data not shown). Costaining with the Golgi marker cis-
Golgi matrix protein of 130kDa (GM130) revealed no
overlap (data not shown). However, expression of the
constitutively inactive Ras-associated binding 11 (Rab11)
S25N mutant showed almost complete overlap with the
Nup62 staining pattern (Figure 6A), indicating that Nup62
localizes in a perinuclear compartment closely related
to the recycling endosomes. Hypothetically, Nup62 is
continually recycled between the perinuclear recycling
compartment and the plasmamembrane, similar to Exo70.
To test thismodel, we blocked exocytic vesicle fusionwith
the plasma membrane using the GTPase-deficient TC10
Q75L mutant, a regulator of Exo70 (51). As expected,
under these conditions EGFP-Exo70 accumulated in a
dense membranous network in the cytoplasm (Figure 6B,
left panel). The small size of the cells attests to the
inhibition of membrane trafficking towards the plasma
membrane. Interestingly, untagged Nup62 was recruited
by Exo70 at these intracellular membranes (Figure 6B).
These results implicate Nup62 in various stages of the
recycling pathway, as evidenced by blocking distinct
steps using GTPase constructs. Figure 6C schematically
summarizes these findings.
Nup62 interacts with the N-domain of Exo70
To further characterize the binding with Exo70, we made
Exo70-truncation constructs (shown in Figure 7A) and
tested them on Nup62 binding in an immunoprecipitation
assay (Figure 7B, results schematized in Figure 7A). All
Exo70-truncation constructs containing the N-domain (full
length, amino acids 1–538 and amino acids 1–393) bound
to Nup62. In contrast, all constructs lacking the N-domain
failed to bind Nup62 (amino acids 539–653 and amino
acids 394–653). To confirm these results, we used the
Exo70-truncation constructs in Arf6 Q67L transfected
HEK cells to determine the in vivo effect on Nup62
localization (Figure 7C). The Exo70 N-domain that interacts
with Nup62, but does not contain the membrane targeting
domain, failed to internalize with plasma membrane
and consequently did not coat the surface of vesicles
(Figure 7C, middle panel). Accordingly, Nup62 was not
recruited to these vesicles (Figure 7C, middle panel). The
Figure 6: Nup62 localizes at the perinuclear recycling
compartment and is recruited by Exo70 at exocytic vesicles.
A) Colocalization of Nup62 and the constitutively inactivated
Rab11 S25N mutant in the perinuclear recycling compartment. B)
Membrane trafficking to the plasma membrane was blocked by
the constitutively activated TC10Q75Lmutant, preventing vesicle
fusion with the plasma membrane and resulting in accumulation
of exocytic vesicles in the cytoplasm. Addition of Exo70 and
Nup62 results in recruitment of Nup62 at Exo70 containing
exocytic vesicles. C) Schematic overview of the data presented
in Figures 4, 5 and 6. Exocyst regulating GTPases Arf6, Rab11
and TC10 were used to demonstrate the linkage between Exo70
and Nup62 through the recycling pathway. Blue arrows indicate
disrupted processes by corresponding GTPase mutants. Scale
bar, 10 μm.
Traffic 2009; 10: 1257–1271 1263
Hubert et al.
complementary Exo70 fragment containing theM- and the
C-domains was enriched at the vesicles but did not recruit
Nup62, in line with the results of the immunoprecipitation
Figure 7: Nup62 interacts with the N-domain of Exo70. The
N-domain of Exo70 is required for interaction with Nup62 inside
living cells. A) Schematic representation of the Exo70 domains.
Positions of first and last amino acids of the domains are indicated.
Exo70 fragments that were used in the immunoprecipitation
assay are represented by bars. Full bars indicate interaction
with Nup62. Open bars indicate no interaction with Nup62. B)
Immunoprecipitation (IP) of double-transfected HEK cell extracts
using anti-EGFP rabbit IgG. Immunoprecipitated EGFP-tagged
full-length, N-domain (amino acids 1–393), M- and C-domain
(amino acids 394–653), N- and M-domain (amino acids 1–538)
and C-domain (amino acids 539–653) of Exo70 were visualized by
immunoblotting (IB) in the upper panel. Co-immunoprecipitated
Nup62 was visualized in the lower panel. Full arrowhead indicates
antibody heavy chain. C) Internalized plasma membrane arrested
in vesicles as a result of transfection with the constitutively
activated Arf6-Q67L mutant. Full-length Exo70 and the M- and
C-domain (amino acids 394–653) of Exo70 contain themembrane
targeting domain and are internalized (left and right upper panels).
The N-domain (amino acids 1–393) of Exo70 does not contain the
membrane targeting domain and is not internalized (middle upper
panel). Nup62 internalization is visualized in the lower panels.
Scale bar, 10 μm.
assay. Although implicit, this information points towards
an essential role for the Exo70 N-domain in Nup62–Exo70
interaction in vivo.
Exo70 binds to the coiled-coil domain of Nup62
Nup62 contains an intrinsically unstructured FG-repeat
containing N-terminal domain (amino acids 1–325) that
supports nucleocytoplasmic exchange of macromolecules
by means of direct contacts with nuclear transport
receptors, and a C-terminal coiled-coil domain (amino
acids 328–522) that contributes to anchoring Nup62
at the NPC. To determine the Exo70 binding site in
Nup62, we tested these Nup62 domains separately
in an immunoprecipitation assay (Figure 8B, results
schematized in Figure 8A). EGFP-Exo70 bound to full-
length Nup62 and to the coiled-coil domain of Nup62
but not to the FG-repeat domain of Nup62 (Figure 8B,
first three lanes). The N-domain of Exo70 also bound to
full-length Nup62 and the coiled-coil domain of Nup62
(Figure 8B, last two lanes). To confirm these results in
vivo, we took advantage of the ability of Exo70 to recruit
Nup62 at filopodia and the plasma membrane. When
co-expressed, Exo70 recruited the coiled-coil domain
Figure 8: Exo70 interacts with the coiled-coil domain but not with the FG-repeat domain of Nup62. A) Schematic representation
of the Nup62 domains. Positions of first and last amino acids of the domains are indicated. Nup62 fragments that were used in the
immunoprecipitation assay are represented by bars. Full bars indicate interaction with Exo70. Open bars indicate no interaction with
Exo70. B) Immunoprecipitation (IP) of double-transfected HEK cell extracts using anti-EGFP rabbit IgG. The Nup62 fragments are referred
to as A (full length), B (amino acids 1–325) and C (amino acids 328–522) according to the schematic representation above. The upper
panel shows V5-tagged Nup62 fragments in total extracts (TE). The lower panel shows immunoprecipitated EGFP-Exo70 (first three
lanes) and EGFP-Exo70N (N-domain, amino acids 1–393 of Exo70; last two lanes). The central panel shows co-immunoprecipitated
Nup62 fragments. C) FG-repeat fragment of Nup62 (amino acids 1–325) localizes at multiple vesicle-like structures near actin-based
membrane protrusions in HEK cells. Actin filaments were visualized by phalloidin staining. D) Co-expression of EGFP-Exo70 and the
FG-repeat fragment of Nup62. The FG-repeat fragment is not targeted to the plasma membrane (left panels) or filopodia (right panels).
E) Co-expression of EGFP-Exo70 and the coiled-coil fragment of Nup62. The coiled-coil fragment is targeted to the plasma membrane
(left panels) and filopodia (right panels). Scale bars, 10 μm.
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Figure 8: Legend on previous page.
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of Nup62 to both filopodia (Figure 8E, right panels)
and the plasma membrane (Figure 8E, left panels) with
equivalent intensity as full-length Nup62 (Figure 4). On
the contrary, the FG-repeat domain of Nup62 remained
entirely insensitive to Exo70 and was not recruited to the
plasma membrane (Figure 8D, left panels) and filopodia
(Figure 8D, right panels). Altogether, these results indicate
that the N-domain of Exo70 interacts with the coiled-coil
domain of Nup62 but not with the FG-repeat domain.
Interestingly, the FG-repeat domain of Nup62 localized at
a multitude of vesicles that specifically concentrated near
actin-based membrane protrusions (Figure 8C).
Removal of the Exo70-binding domain of Nup62
prevents leading edge localization of Nup62
Expression of the coiled-coil domain of Nup62 revealed a
large increase in the perinuclear localization of Nup62,
indicating that the cycling of Nup62 was impaired,
resulting in an accumulation of the Nup62 fragment
in the perinuclear recycling compartment (Figure 9B,
upper left panels; results schematized in Figure 9A).
These results indicate that the FG-repeat domain
of Nup62 is needed for transport of Nup62 from
the perinuclear recycling compartment to the plasma
membrane. Expression of the FG-repeat domain of Nup62
showed two interesting localization motifs. First, this
domain decorated microtubules but not actin filaments
(Figure 9B, upper right panels and data not shown; results
schematized in Figure 9A), suggesting a possible transient
association of Nup62 with microtubules via a motor
protein. This characteristic explains how Nup62 might
be transported to the cell surface and why deletion
of this domain results in retention of Nup62 in the
perinuclear recycling compartment. Accordingly, when
microtubules are depolymerized by nocodazole treatment,
the localization of the FG-repeat domain of Nup62
becomes completely uniform throughout the cell, lacking
any subcellular accumulation (Figure S1D). Second, the
FG-repeat domain of Nup62 accumulated in densely
packed vesicle-like structures in the vicinity of membrane
protrusions (Figures 8C and 9B, lower panels; results
schematized in Figure 9A). This pool is prevented from
associating with the plasma membrane because of the
absence of the coiled-coil domain. Thus, equivalently,
removal of the Exo70-binding domain results in impaired
docking at membrane protrusions.
Discussion
Nucleoporins constitute the pores in the nuclear mem-
brane through which all nucleocytoplasmic transport
occurs (reviewed in (52)). Most proteins that need to cross
the nuclear membrane require nuclear transport receptors
that depend on nucleoporins for translocation. Nup62 is
a nucleoporin that localizes in the central channel of the
NPC (53) and occasionally also binds cargo directly to sup-
port nuclear import (7). So far, Nup62 has never been
reported in other compartments of the cell. Therefore,
the most obvious explanation for the Nup62–Exo70 inter-
action described here would be Nup62-assisted nuclear
import of Exo70. However, both endogenous Exo70 stain-
ing using a monoclonal antibody (41) and expression of
EGFP-tagged Exo70 (46) revealed no sign of nuclear local-
ization of Exo70. Moreover, none of our Exo70 truncation
constructs localized in the nucleus except those with a
molecular mass below the limit for passive diffusion which
is estimated at 30–60 kDa (Figure 7C and data not shown).
Nevertheless, the rabbit anti-Exo70 antibody used in this
study gives some uniform nuclear staining. As a result,
we cannot exclude completely the possibility that Nup62
assists Exo70 in nuclear transport. Even so, the presence
of Nup62 at the leading edge and the recruitment of Nup62
at the plasma membrane and filopodia by Exo70 indicate
an alternative function for the Nup62–Exo70 interaction.
Moreover, Exo70 interacts with the coiled-coil domain of
Nup62 and not with the FG-repeat domain that supports
nucleocytoplasmic transport (7,52).
In this study, we report a major pool of Nup62 in the
cytoplasm. High levels of cytoplasmic Nup88 have also
been observed by others but this has not been further
studied so far (54). RNA interference of Nup62 with two
independent siRNA duplexes greatly reduced the cyto-
plasmic pool of Nup62 without affecting the NPC pool.
Furthermore, Nup62 is no longer recruited to the leading
edge after Nup62 RNA interference. This indicates that
the cytoplamic and leading edge Nup62 stainings are not
staining artefacts but represent important Nup62 pools
that have not been investigated so far. The sustained
localization of Nup62 at the nuclear membrane up to 72 h
after siRNA transfection is surprising as the overall resi-
dence time of Nup62 at the NPC has been estimated at
13 h, which is significantly less than that of structural scaf-
fold nucleoporins (12). This probably reflects incomplete
Nup62 mRNA degradation and preferential replenishment
Figure 9: Expression of Nup62 fragments. A) Schematic representation of the subcellular localization of Nup62 and Nup62 fragments
shown in (B). N, nucleus. B) Expression of Nup62 and Nup62 fragments in HEK cells. Full-length Nup62 (amino acids 1–522) localizes
at membrane protrusions and at the perinuclear recycling compartment. The coiled-coil domain of Nup62 (amino acids 328–522)
accumulates strongly in the perinuclear recycling compartment. The FG-repeat fragment of Nup62 (amino acids 1–325) localizes at
microtubules (α-tubulin; upper right panels) and concentrates at vesicle-like structures in the neighbourhood of membrane protrusions
(lower panels). Blue, DAPI. Scale bars, 10 μm. C) Model of Nup62 and Exo70 functioning. Question marks indicate unknown microtubule
motor protein complex and unknown effect on exocytosis. Blue arrows indicate disrupted processes by corresponding Nup62 domain
deletions. Deletion of the FG-repeat domain results in a block of Nup62 transport and, consequently, a strong accumulation of Nup62
at the perinuclear recycling compartment. Removal of the Exo70-binding domain of Nup62 prevents plasma membrane localization of
Nup62. MT, microtubule; PNRC, perinuclear recycling compartment.
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Figure 9: Legend on previous page.
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of the essential Nup62 pool at the NPC. Alternatively, the
residual amount of Nup62 seen in the western blot and
immunostaining could represent a stable subpopulation
due to protective complex formation or post-translational
modification. Whatever the cause, this partial knock-down
allowed us to study specifically the function of cytoplas-
mic and leading edge Nup62 without having to deal with
perturbation of nucleocytoplasmic transport which would
have a major impact on cell homeostasis.
At the leading edge, Exo70 is known to be indispensable
for two aspects of cell migration: recruitment of the
actin polymerization factor Arp2/3 (41) and targeting of
exocytic vesicles (38). In migrating PC3 cells, in Rac Q61L
transfected HEK cells or in EGF-stimulated HeLa cells,
Nup62 is targeted to the leading edge. Relocalization
of Nup62 to the leading edge was completely inhibited
after Nup62 RNA interference. Simultaneous expression
of Nup62 and Exo70 revealed that Nup62 is recruited by
Exo70. Exo70 knock-down would therefore be expected
to block Nup62 relocalization to the cells front. This
prediction however cannot be verified because inhibition
of Exo70 prevents formation of actin-based membrane
protrusions (41). To circumvent this problem, we removed
the Exo70-binding domain of Nup62, resulting in impaired
leading edge localization of Nup62. Inversely, Nup62
knock-down did not block Arp3 localization at membrane
protrusions and thus does not interfere with the ability of
Exo70 to recruit the Arp2/3 complex (41). Nevertheless,
Nup62 has an active role in cell migration as reflected
by the dramatic reduction in migrated distance of cells
lacking Nup62 in the cytoplasm and at the leading edge.
Exo70 and other exocyst components also localize to
other cellular compartments, including the Golgi appara-
tus, the trans Golgi network, the early endosomes and
Rab11-positive recycling endosomes (49). Exo70 is likely
to continuously cycle between these compartments and
the plasma membrane. Based on the observation that
expressed untagged Nup62 localizes at a pericentriolar
organelle (data not shown), we considered possible recy-
cling of Nup62. We first identified this organelle as related
to the Rab11-positive recycling endosomes. To study
other steps in the recycling pathway, we blocked traffick-
ing membrane from and towards the plasma membrane
using constitutively activated Arf6 and TC10 (two exocyst-
regulating small GTPases), respectively (50,51). In both
cases, as trafficking membranes became trapped in large
cytoplasmic pools, Exo70 was able to recruit Nup62 at the
surface of these membranes. These results suggest that
Nup62 is able to accompany Exo70 through the recycling
pathway. Furthermore, when the recycling of Nup62 is
blocked by deleting its FG-repeat domain, Nup62 strongly
accumulates in the perinuclear recycling compartment.
Exo70 interacts via its N-terminal domain with the coiled-
coil domain of Nup62. The delineation of the interaction
interface raises two important questions. First, since it
is through its N-terminal domain that Exo70 recruits the
other exocyst subunits, Nup62 may possibly facilitate,
compete for, or sense complex formation and thus
influence exocyst complex formation directly or indirectly.
However, it should be noted that sec3 and sec8–two other
exocyst components – failed to interact with Nup62.
Second, as suggested in Figure 8C, the FG-repeat domain
of Nup62 may well be involved in exocytosis but
does not bind Exo70. Indeed, without structural and
targeting information provided by the coiled-coil domain,
Nup62 localizes at numerous vesicles near membrane
protrusions. Possibly, Nup62 binds other components of
the membrane trafficking pathway through its FG-repeat
domain. One such candidate is Syntaxin 2, a SNARE
protein involved in membrane fusion. Preliminary findings
point to an interaction between Nup62 and Syntaxin 2
(data not shown) but these data have to be interpreted
carefully because both the FG-repeat domain of Nup62
and SNARE proteins contain hydrophobic domains.
Because nucleoporins tend to function in stable multicom-
ponent modules both in interphase and in mitosis (2,55),
Nup62 most likely cooperates with other components
of the Nup62-Nup58-Nup45-Nup54 and Nup214-Nup88-
Nup62 subcomplexes at the cells front. It is puzzling that
both structural scaffold (Nup84/Nup107 complex), struc-
tural adaptor (Nup98 and Nup62 complexes) and dynamic
(Nup153) nucleoporin modules have been assigned alter-
nate cellular tasks (12). Furthermore, these nucleoporin
modules tend to regulate highly dynamic and complex
molecular machines such as the NPC, the anaphase
promoting complex (APC), the kinetochore, the mitotic
spindle and possibly the transcriptosome (56). This study
adds the exocyst complex as a possible target of a nucle-
oporin module.
Nevertheless, non-canonical nucleoporin functions appear
more comprehensible in the context of recent insights
into normal interphase NPC functioning. For example,
Nup358 is a nucleoporin with SUMO E3 ligase activity
that stably interacts with the SUMO E2-conjugating
enzyme Ubc9 at the NPC (57). Surprisingly, in mitosis,
topoisomerase IIα requires sumoylation by Nup358 to
localize correctly at the centromeres to decatenate
sister centromeres before anaphase (21). This unexpected
function of Nup358 in mitosis is quite remarkable but
is certainly made more comprehensible by the finding
that, in interphase, Nup358 also sumoylates HDAC4
deacetylase at the entrance of the nuclear pore (27).
In addition, other (de)sumoylation enzymes necessitate
NPC localization to work properly (18). Thus, the view
emerges that the cell exploits the central position of
the nuclear pore to perform additional tasks at the
NPC such as (de)sumoylation (58). This may explain why
numerous nucleoporins have extended their work field
beyond the nuclear pore, which makes little sense from
the viewpoint of nucleocytoplasmic transport alone (56).
In this perspective, exploring the functioning of Nup62
at the cell front might also lead to new insights into the
working of the NPC.
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Materials and Methods
Plasmids and siRNAs
Nup62 (IRATp970E1077D), Cep55 (IRAUp969A0230D), Annexin 11
(IRAUp969G0537D) and Aurora B (IRAUp969D1049D) were obtained from
ImaGenes (Germany). EGFP-rab11 and EGFP-rab11 S25N were a kind
gift from Professor S. Ferguson (Robarts Research Institute London, ON,
Canada). Myc-TC10 Q75L plasmid was a kind gift from Professor J. Pessin
(Albert Einstein College of Medicine, NY, USA). The NTF2 cDNA was a
kind gift from Professor J. P. Siebrasse (Institut fu¨r Medizinische Physik
und Biophysik, Universita¨t Mu¨nster, Germany). EGFP-Sec3, Exo70-EGFP
and EGFP-Exo70 plamids were a kind gift from Dr R. Scheller (Genen-
tech Inc.). HA-Arf6-Q67L was a kind gift from Dr B. Wehrle-Haller (Centre
Medical Universitaire, Geneva, Switzerland). Myc-tagged PIP5 kinase 1α
was previously used (59). EGFP-PH-PLCδ was previously described (60).
GST-Exo70 was a kind gift from Dr W. Guo (University of Pennsylva-
nia, PA, USA). cDNAs were subcloned into the EGFP-N1 vector, the
EGFP-C1 vector (Clontech-Takara Bio Europe) or the pCTAP-A vector
containing the SBP and calmodulin binding peptide (CBP) sequences
(InterPlay™ Mammalian TAP System; Stratagene). V5 tag (GKPIPNPLL-
GLDST) was cloned in the pET SUMO vector (Invitrogen). pGEX−5X−1
vector was from GE Healthcare. Nup62 fragments were subcloned into
the pcDNA3.1/V5-His/TOPO or the pET SUMO vector (Invitrogen). Small
interfering RNAs against Nup62 were purchased from Eurogentec (Nup62
siRNA1 = CCUACAAGCUGGCUGAGAAtt + UUCUCAGCCAGCUUGUAG-
Gtt; Nup62 siRNA2 = GCAACUGCUCCAACCUCAUtt + AUGAGGUUG-
GAGCAGUUGCtt).
Antibodies
The following antibodies were used: mouse antibody to Nup62, clone
53 (BD Biosciences Pharmingen #610497); mouse antibody to CBP tag
(Upstate #07–482); rat anti-HA antibody, clone 3F10 (Roche #1867423);
mouse antibody to actin, clone C4 (MP Biomedicals #691001); mouse
antibody to V5 (Invitrogen #R960−25); mouse antibody to Exo70 (Abcam
#ab57402); mouse antibody to Sec8 (BD Transduction Laboratories
#610658), goat antibody to glutathione S-transferase (GST) (GE Healthcare
#27457701). Mouse antibody to myc and rabbit antibody to EGFP were
home made. Rabbit Exo70 antibody was a kind gift from Professor C.
Yeaman (University of Iowa, USA). Secondary antibodies and Alexa Fluor
488-tagged phalloidine were from Molecular Probes (Invitrogen).
Cell culture and transfection
PC3 cells were maintained at 37◦C in a humidified 10% CO2 incubator and
grown in RPMI−1640 (Gibco BRL Life Technologies) supplemented with
10% fetal bovine serum, 100 μg/mL streptomycin and 100 IU/mL penicillin.
HeLa and HEK293T cells were grown in DMEM with 10% fetal bovine
serum, 100 μg/mL streptomycin and 100 IU/mL penicillin. HeLa and PC3
cells were transiently transfected using lipofectamine reagent (Invitrogen)
according to the manufacturer’s instructions. HEK293T cells, seeded
on rat tail collagen-coated coverslips, were transfected using calcium
phosphate. For EGF (Sigma-Aldrich) treatment, HeLa cells were plated
on collagen-coated coverslips, serum starved overnight and subsequently
stimulated with 20 ng/mL EGF for 3 up to 15 min before processing for
immunofluorescence microscopy.
Pull-down, immunoprecipitation, in vitro binding
and western blotting
Cells were disrupted in ice-cold lysis buffer [50 mM Tris–HCl pH 7.5,
150 mM NaCl, 1 mM MgAc, 1% Triton-X−100, 2 mM dithiothreitol, 5 mM
sodium fluoride, 2 mM sodium orthovanadate, 1 mM phenylmethylsulpho-
nyl fluoride (PMSF) and a protease inhibitor cocktail mix] using a tip
sonicator. Insoluble material was removed by centrifugation (14000× g for
10 min at 4◦C). Protein concentrations were determined by the method of
Bradford (61) using BSA as a standard. For immunoprecipitation, 500 μg
of cleared cell lysate was incubated with 1 μg antibody for 2 h at 4◦C and
bound proteins were recovered with protein G–Sepharose (GE Health-
care). For pull-downs, 500 μg of cell lysate was incubated with 40 μL
of streptavidin resin slurry (Pierce) for 2 h at 4◦C. For in vitro binding
of GST/GST-Exo70 with SUMO-V5/SUMO-Nup62(328–522)-V5, proteins
were expressed in TOP10 or BL21(DE3) (Invitrogen) cells, respectively,
after induction with 1 mM IPTG, overnight at 20◦C. Equal amounts of cell
extracts were incubated, washed and purified using Glutathion Sepharose
4 Fast Flow (GEHealthcare Bio-Sciences).Western blottingwas performed
as described (62). Proteins were visualized by enhanced chemilumines-
cence detection (Amersham Pharmacia Biotech).
Immunostaining and immunofluorescence
microscopy
For fixation, cells were washed with PBS, fixed with 3% paraformaldehyde
for 20 min at room temperature and permeabilizedwith 0.2% Triton-X−100
in PBS for 5 min. Paraformaldehydewas neutralizedwith 0.75% glycine for
20 min. Cellswere then blocked in 1%BSA in PBS for 30 min and incubated
with primary antibody for 1 h at 37◦C. Cells were washed in PBS, then
incubated with secondary antibody (Alexa 488-conjugated goat anti-rabbit
or Alexa 594-conjugated goat anti-mouse; Molecular Probes) and 4,6-
diamidino−2-phenylindole (DAPI; Sigma) for 30 min at room temperature.
Following immunostaining, samples were analysed using a Carl Zeiss
Axiovert 200M Apotome epifluorescence microscope [63x 1.4 numerical
aperture (NA) oil objective] equipped with an Axiocam cooled charge-
coupled device (CCD) camera and processed using Axiovision software
(Zeiss).
Wound-healing assay
PC3 cells (n = 900000) were seeded into six-well cell culture plates.
Twenty-four hours after seeding, cells were transfected with either Nup62
siRNA1, with Nup62 siRNA2, with the negative control siRNA provided
by Eurogentec or with water (mock). Forty-eight hours after transfection
wounds were made by scratching three lines in a confluent monolayer. For
each line, three measure points were marked resulting in nine measure
points per well. Cell debris was removed by extensively washing the cells
with PBS and medium. After 0, 4, 8 and 24 h the width of the wound was
measured at the marked locations.
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Supporting Information
Additional Supporting Information may be found in the online version of
this article:
Figure S1: Immunofluorescence microscopy experiments. A)HEK cells
were transfected with EGFP-Nup62 or Nup62-EGFP and subsequently
stained for Arp3 to demonstrate the presence of EGFP-tagged Nup62
in membrane protrusions (enlarged areas). B) HEK cells were stained for
Nup88, Nup58/45, Nup54 and Arp3 or Nup62 to demonstrate the presence
of Nup88, Nup58/45 and Nup54 in membrane protrusions (enlarged areas).
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C) EGFP-Exo70 in control and Leptomycin B (LMB)-treated HEK cells.
D) HEK cells were transfected with Nup62(1–325)-V5 and subsequently
treated with nocodazole to depolymerize microtubules. α-Tubulin staining
shows depolymerized microtubules. V5 staining shows the localization of
Nup62(1–325)-V5. Scale bar, 10 μm.
Figure S2: Time lapse microscopy of Nup62 knock-down cells. PC3
cells were transfected with Alexa 488-conjugated control siRNAs or
Nup62 siRNAs and stained for Nup62 to demonstrate the efficacy of the
knock-down.
Figure S3: Nup62 knock-down does not interfere with cell cycle entry
or cell cycle distribution in a HeLa cell population. FACS analysis
of HeLa cells transfected with water (mock), control siRNAs of Nup62
siRNAs, as indicated at the left. The purple diagrams represent the
distribution of cells in function of their DNA content as measured by
propidium iodide (PI) fluorescence (left panels). The first maximum in
the distribution corresponds to 2n or G1 cells, while the second, lower,
maximum corresponds to 4n or M cells. In between the two maxima are
the replicating cells with a DNA content between 2n and 4n. To analyse
cell cycle entry, cells were treated with nocodazole to depolymerize
microtubules and arrest cells in M phase (right panels). As a result, cells
are blocked when they have a 4n DNA content and the higher maximum
in the diagram shifts from 2n to 4n.
Video S1: Control cells migrate normally. Time lapse video of 30 min of
PC3 cells transfected with control siRNA.
Video S2: Nup62 knock-down cells show disrupted cell migration. Time
lapse video of 30 min of PC3 cells transfected with Nup62 siRNA1.
Please note: Wiley-Blackwell are not responsible for the content or
functionality of any supporting materials supplied by the authors.
Any queries (other than missing material) should be directed to the
corresponding author for the article.
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